• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • AI SuperconnectorNEW
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • AI SuperconnectorNEW
  • Settings
  • RSS Feeds
PublishGo to AppAI Superconnector
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEW
    Legal
    Terms of usePrivacy policyCookie policy

    Fundbox Appoints Hilliard Terry to Board of Directors

    6/22/21 12:00:00 PM ET
    $UPST
    $TGH
    $A
    $TLGA
    Finance: Consumer Services
    Finance
    Diversified Commercial Services
    Consumer Discretionary
    Get the next $UPST alert in real time by email

    SAN FRANCISCO, CA, June 22, 2021 (GLOBE NEWSWIRE) -- Fundbox, the financial platform for small businesses, announced today that it has appointed Hilliard Terry to its Board of Directors. Mr. Terry is an experienced executive leader, corporate board member and advisor to private equity backed portfolio companies.  

    Mr. Terry currently serves on the board of directors of Umpqua Holdings Corporation (NASDAQ:UMPQ), a financial services company. He also serves on the board of directors of Upstart Holdings, Inc. (NASDAQ:UPST), a leading artificial intelligence consumer lending platform, and on the board of TLG Acquisition One Corporation (NYSE:TLGA), a special purpose acquisition company.

    "Hilliard is an accomplished public company CFO and a seasoned board member with an impressive record of achievement at the intersection of technology, finance, and banking," said Prashant Fuloria, CEO of Fundbox. "We are thrilled to benefit from his operating and board experience in this time of opportunity and growth post-COVID."

    Mr. Terry has recently served as an advisor to private companies and previously as Executive Vice President and Chief Financial Officer of Textainer (NYSE:TGH). Prior to Textainer, Mr. Terry was Vice President and Treasurer at Agilent Technologies (NYSE:A), and was the Head of Investor Relations during their IPO and subsequent spin-off from Hewlett-Packard. Before joining Agilent, he worked in marketing and investor relations for HP's VeriFone subsidiary. Mr. Terry has also held positions in investor relations and investment banking with Kenetech Corporation and Goldman, Sachs & Co., respectively. He is a qualified financial expert with operating experience and in-depth knowledge of accounting, treasury, investor relations, financial planning & analysis, risk management and corporate development.

    "Through their AI-powered platform, Fundbox is providing access to credit for a much broader community of small businesses, a sector that has been underserved in the past. This is critically important and fundamentally different from anything that has ever been done before," said Mr. Terry. "There is a massive market opportunity ahead and I look forward to rolling up my sleeves and diving into areas like governance and compliance, which are critical fields of investment for a company at this stage." 

    The company is poised for massive growth as the small business economy recovers and expands post-COVID. Recent research has shown that Americans started 4.4 million businesses in 2020, a 24% increase from the year prior, and the first time in history that new businesses have increased during a recession. 

    Fundbox provides access to financial tools that enable small business owners to cover business-critical operating expenses. Their AI technology has enabled the company to scale quickly through automation while increasing access to capital through superior predictions and credit decisions. Fundbox's process is fully automated, and 99% of their decisions are made without human intervention.

    About Fundbox

    Fundbox is a financial platform for small businesses. The company is on a mission to unlock growth for small businesses by providing fast and easy access to financial tools and working capital solutions.  Fundbox has connected with nearly 300,000 businesses, unlocked over $2B in working capital, and invested $100M into its AI platform, gaining deep insights into the small business ecosystem.

    The company has received numerous awards including the prestigious Forbes Best Startup Employers and AI 50, Red Herring Top North American 250, CB Insights Fintech 250, and Fintech Breakthrough Awards. Founded in 2013, Fundbox currently has 200+ employees and offices in San Francisco, CA; Dallas, TX; and Tel Aviv, Israel.



    Liz Berman
    Allison+Partners
    908-566-2090
    [email protected]
    
    Get the next $UPST alert in real time by email

    Crush Q3 2025 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $UPST
    $TGH
    $A
    $TLGA

    CompanyDatePrice TargetRatingAnalyst
    Upstart Holdings Inc.
    $UPST
    8/20/2025$88.00Neutral → Overweight
    Analyst
    Upstart Holdings Inc.
    $UPST
    7/14/2025$71.00Sell
    Goldman
    Upstart Holdings Inc.
    $UPST
    6/24/2025$75.00Overweight
    Piper Sandler
    Upstart Holdings Inc.
    $UPST
    6/12/2025$55.00Equal-Weight
    Stephens
    Upstart Holdings Inc.
    $UPST
    4/29/2025$53.00Underperform → Neutral
    BofA Securities
    Upstart Holdings Inc.
    $UPST
    2/14/2025$12.00 → $70.00Underweight → Equal-Weight
    Morgan Stanley
    Upstart Holdings Inc.
    $UPST
    2/12/2025$57.00 → $79.00Underweight → Neutral
    Analyst
    Upstart Holdings Inc.
    $UPST
    2/12/2025$49.00 → $105.00Neutral → Buy
    B. Riley Securities
    More analyst ratings

    $UPST
    $TGH
    $A
    $TLGA
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    Upstart upgraded by Analyst with a new price target

    Analyst upgraded Upstart from Neutral to Overweight and set a new price target of $88.00

    8/20/25 8:20:55 AM ET
    $UPST
    Finance: Consumer Services
    Finance

    Goldman resumed coverage on Upstart with a new price target

    Goldman resumed coverage of Upstart with a rating of Sell and set a new price target of $71.00

    7/14/25 8:56:38 AM ET
    $UPST
    Finance: Consumer Services
    Finance

    Piper Sandler resumed coverage on Upstart with a new price target

    Piper Sandler resumed coverage of Upstart with a rating of Overweight and set a new price target of $75.00

    6/24/25 8:25:23 AM ET
    $UPST
    Finance: Consumer Services
    Finance

    $UPST
    $TGH
    $A
    $TLGA
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    KBRA Assigns Preliminary Ratings to Upstart Securitization Trust 2025-3

    KBRA assigns preliminary ratings to four classes of notes issued by Upstart Securitization Trust 2025-3 ("UPST 2025-3"), a $320 million consumer loan ABS collateralized by unsecured consumer loans. The preliminary ratings reflect initial credit enhancement levels of 56.45% for the Class A notes, 43.50% for the Class B notes, 33.30% for the Class C notes and 20.50% for the Class D notes. Credit enhancement consists of overcollateralization, excess spread, a non-declining cash reserve account and subordination (except for the Class D notes). UPST 2025-3 represents the 47th ABS securitization collateralized by unsecured consumer loans originated through the online platform operated by Upst

    9/5/25 1:52:00 PM ET
    $UPST
    Finance: Consumer Services
    Finance

    Agilent to Showcase New Dako Omnis Family at European Congress of Pathology 2025

    Agilent Technologies Inc. (NYSE:A) today announced its participation as a premium sponsor at the upcoming European Congress of Pathology (ECP) 2025, taking place in Vienna, Austria, from September 6–10, 2025. Agilent will spotlight the European launch of its newly expanded Dako Omnis Family of instruments. The Dako Omnis family, including the Dako Omnis 110, 165, and 165 Duo models, is built to provide flexibility, consistency, and efficiency across labs of all sizes. Designed to meet the evolving needs of modern pathology labs, these instruments, are backed up by Agilent's dedicated service and support teams to help ensure reliable operations and confident diagnoses. "Our presence at E

    9/3/25 8:00:00 AM ET
    $A
    Biotechnology: Laboratory Analytical Instruments
    Industrials

    Agilent's MMR IHC Panel pharmDx (Dako Omnis) Receives European IVDR Certification as a Companion Diagnostic Test for Colorectal Cancer

    Agilent Technologies Inc. (NYSE:A) today announced that its MMR IHC Panel pharmDx (Dako Omnis) has received class C companion diagnostic (CDx) certification under EU in vitro diagnostic regulation (IVDR)1 as a CDx test for colorectal cancer. MMR IHC Panel pharmDx (Dako Omnis) is indicated as an aid to identify mismatch repair (MMR) deficient CRC patients eligible for treatment with OPDIVO® (nivolumab) in combination with YERVOY® (ipilimumab). MMR IHC Panel pharmDx (Dako Omnis) is approved for exclusive use with the Agilent Dako Omnis automated staining solution. The MMR pathway corrects DNA replication errors to maintain genomic stability2. Dysfunction in key MMR proteins (MLH1, PMS2, MSH

    9/2/25 8:00:00 AM ET
    $A
    Biotechnology: Laboratory Analytical Instruments
    Industrials

    $UPST
    $TGH
    $A
    $TLGA
    SEC Filings

    View All

    SEC Form 144 filed by Upstart Holdings Inc.

    144 - Upstart Holdings, Inc. (0001647639) (Subject)

    9/3/25 4:21:26 PM ET
    $UPST
    Finance: Consumer Services
    Finance

    SEC Form 10-Q filed by Agilent Technologies Inc.

    10-Q - AGILENT TECHNOLOGIES, INC. (0001090872) (Filer)

    8/29/25 4:33:55 PM ET
    $A
    Biotechnology: Laboratory Analytical Instruments
    Industrials

    Agilent Technologies Inc. filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits

    8-K - AGILENT TECHNOLOGIES, INC. (0001090872) (Filer)

    8/27/25 4:06:24 PM ET
    $A
    Biotechnology: Laboratory Analytical Instruments
    Industrials

    $UPST
    $TGH
    $A
    $TLGA
    Leadership Updates

    Live Leadership Updates

    View All

    Agilent Showcases Solutions and Partnerships Transforming Cancer Research and Therapeutics at AACR 2025

    Agilent Technologies Inc. (NYSE:A) announced today its participation at the American Association for Cancer Research (AACR) Annual Meeting on April 25-30, 2025 in Chicago, Illinois. Innovative Agilent products and partnerships playing a crucial role in transforming cancer research, diagnostics, and therapeutics will be featured, including: Agilent Avida DNA Cancer Panels – Based on cutting-edge next-generation sequencing (NGS) target enrichment solutions that enable simultaneous DNA and methylation profiling from a single sample, the Avida product portfolio has expanded to include three new DNA panels*. Optimized based on the requirements of the European OncNGS Consortium, these catalog p

    4/24/25 8:00:00 AM ET
    $A
    Biotechnology: Laboratory Analytical Instruments
    Industrials

    Broadway Financial Corporation Announces New Board Member

    LOS ANGELES, March 10, 2025 /PRNewswire/ -- Broadway Financial Corporation ("Broadway" or the "Company") (NASDAQ:BYFC), parent company of City First Bank, National Association (the "Bank"), is pleased to announce the appointment of Mary Hentges to its board of directors (the "Board"), effective March 5, 2025, to fill the vacancy on the Board after its size was increased to ten directors. Ms. Hentges will serve on the Audit Committee of the Board of the Company and the Bank, and on the Risk and Compliance Committee and Internal Asset Review Committee of the Bank. Ms. Hentges wi

    3/10/25 5:25:00 PM ET
    $BYFC
    $UPST
    Savings Institutions
    Finance
    Finance: Consumer Services

    Upstart Appoints Peter Bernard to Its Board of Directors

    Upstart (NASDAQ:UPST), the leading AI lending marketplace, today announced that Peter Bernard has been appointed to the company's Board of Directors. "We're thrilled to welcome Peter to the Upstart Board," said Dave Girouard, co-founder and CEO of Upstart. "Peter's deep expertise in banking and risk management, and rich knowledge of public and private markets, will be particularly valuable as we continue to innovate and expand on the funding side of our business." "Like Upstart, I believe AI is making lending more affordable, inclusive, and transparent," said Bernard. "It's an exciting time in Upstart's evolution and I look forward to helping Dave, Paul, and the team build an enduring com

    2/19/25 9:00:00 AM ET
    $UPST
    Finance: Consumer Services
    Finance

    $UPST
    $TGH
    $A
    $TLGA
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    SEC Form 4 filed by Gonsalves Rodney (Amendment)

    4/A - AGILENT TECHNOLOGIES, INC. (0001090872) (Issuer)

    10/20/23 1:07:25 PM ET
    $A
    Biotechnology: Laboratory Analytical Instruments
    Industrials

    Gonsalves Rodney bought $288 worth of shares (3 units at $111.09), increasing direct ownership by 0.01% to 24,222 units (SEC Form 4)

    4 - AGILENT TECHNOLOGIES, INC. (0001090872) (Issuer)

    9/29/23 4:03:46 PM ET
    $A
    Biotechnology: Laboratory Analytical Instruments
    Industrials

    $UPST
    $TGH
    $A
    $TLGA
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Chief Legal Officer Darling Scott exercised 4,000 shares at a strike of $13.22 and sold $277,654 worth of shares (4,000 units at $69.41) (SEC Form 4)

    4 - Upstart Holdings, Inc. (0001647639) (Issuer)

    9/5/25 4:37:38 PM ET
    $UPST
    Finance: Consumer Services
    Finance

    Chief Technology Offier Gu Paul sold $343,059 worth of shares (5,000 units at $68.61) and exercised 5,000 shares at a strike of $6.34 (SEC Form 4)

    4 - Upstart Holdings, Inc. (0001647639) (Issuer)

    9/4/25 5:48:21 PM ET
    $UPST
    Finance: Consumer Services
    Finance

    Officer Mirgorodskaya Natalia sold $99,593 worth of shares (1,439 units at $69.21), decreasing direct ownership by 6% to 21,081 units (SEC Form 4)

    4 - Upstart Holdings, Inc. (0001647639) (Issuer)

    9/4/25 5:47:05 PM ET
    $UPST
    Finance: Consumer Services
    Finance

    $UPST
    $TGH
    $A
    $TLGA
    Financials

    Live finance-specific insights

    View All

    Agilent Reports Third-Quarter Fiscal Year 2025 Financial Results

    Agilent delivers strong revenue growth, raises growth outlook  Highlights Revenue of $1.74 billion for the third quarter ended July 31, 2025, exceeding revenue guidance and representing growth of 10.1% reported and up 6.1% on a core(1) basis compared with the third quarter of 2024. GAAP net income of $336 million; earnings per share (EPS) of $1.18, up 22% from the third quarter of 2024. Non-GAAP(2) net income of $390 million; EPS of $1.37, up 4% from the third quarter of 2024. These results reflect a full quarter of the dynamic tariff environment. Outlook for full 2025 fiscal year and Q4 Full-year revenue outlook revised at a range of $6.91 billion to $6.93 billion, repr

    8/27/25 4:05:00 PM ET
    $A
    Biotechnology: Laboratory Analytical Instruments
    Industrials

    Upstart Announces Results for Second Quarter 2025

    Upstart Holdings, Inc. (NASDAQ:UPST), the leading artificial intelligence (AI) lending marketplace, today announced financial results for the quarter ended June 30, 2025. Upstart will host a conference call and webcast at 1:30 p.m. Pacific Time today. An earnings presentation and link to the webcast are available at ir.upstart.com. "A year ago, you saw the first signs that Upstart was returning to growth mode - and today you can see it in full bloom," said Dave Girouard, Co-founder and CEO of Upstart. "In addition to achieving triple-digit revenue growth, we reached GAAP profitability a quarter sooner than expected and our newer businesses actually accelerated off their amazing growth in

    8/5/25 4:05:00 PM ET
    $UPST
    Finance: Consumer Services
    Finance

    Agilent to Announce Third-Quarter Fiscal Year 2025 Financial Results on Aug. 27

    Following an announcement earlier this week, Agilent Technologies Inc. (NYSE:A) confirms it will release financial results for the third quarter of fiscal year 2025 after the stock market closes on Wednesday, Aug. 27. In addition, the company will host a conference call to discuss the results at 1:30 p.m. PDT on the same day. To join the listen-only conference call webcast, click the link on the Events section of Agilent's investor relations website. A recording of the call also will be available on the website for 90 days. About Agilent Technologies Agilent Technologies Inc. (NYSE:A) is a global leader in analytical and clinical laboratory technologies, delivering insights and innova

    7/17/25 4:30:00 PM ET
    $A
    Biotechnology: Laboratory Analytical Instruments
    Industrials

    $UPST
    $TGH
    $A
    $TLGA
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    Amendment: SEC Form SC 13G/A filed by Agilent Technologies Inc.

    SC 13G/A - AGILENT TECHNOLOGIES, INC. (0001090872) (Subject)

    11/12/24 1:27:37 PM ET
    $A
    Biotechnology: Laboratory Analytical Instruments
    Industrials

    SEC Form SC 13G filed by Agilent Technologies Inc.

    SC 13G - AGILENT TECHNOLOGIES, INC. (0001090872) (Subject)

    11/12/24 11:54:03 AM ET
    $A
    Biotechnology: Laboratory Analytical Instruments
    Industrials

    SEC Form SC 13G filed by Agilent Technologies Inc.

    SC 13G - AGILENT TECHNOLOGIES, INC. (0001090872) (Subject)

    11/4/24 10:57:57 AM ET
    $A
    Biotechnology: Laboratory Analytical Instruments
    Industrials